Cell Signaling & Oncology

Axon Ligands™ for Cell Signaling & Oncology Research

The signaling pathways controlling cell growth and differentiation are almost invariably altered in cancer. During the course of tumor progression, cancer cells acquire a number of characteristic alterations. These include the capacities to proliferate independently of exogenous growth-promoting or growth-inhibitory signals, to invade surrounding tissues and metastasize to distant sites, to elicit an angiogenic response, and to evade mechanisms that limit cell proliferation, such as apoptosis and replicative senescence. These properties reflect alterations in the cellular signaling pathways that in normal cells control cell proliferation, motility, and survival. These interconnected pathways are being deciphered, but understanding the alterations that lead to cancer and correcting them is a substantial challenge. Among the key pathways are those controlling cell proliferation, which coordinate a response to the cellular environment, with the mTOR kinase as a critical node. Tumour development is influenced by infections and inflammation, and the complex role of the nuclear factor-B transcription factors is being unravelled. Expansion of tumour cells depends on nutrient supply and vascularization, which is orchestrated by the transcription factor known as HIF. And the metastatic spread of primary tumours to other organs is facilitated by many signaling pathways[1],[2].

Cell Signaling and Oncology products Library

For your convenience, you can order a library of all of our Cell Signaling and Oncology research related products. Make your personal library by cherry picking products of your interest from our comprehensive list (>800 products), or order all together not to miss any. The libraries will be shipped as 10 mM solutions (in DMSO, 250 µL of each selected Axon Ligand™) on a 96-well microtiter plate with a clear map of its contents.

Simply download our comprehensive list of epigenetics products below (Microsoft Excel (.xls)), check the products to be included, and return your list to order the library of your preference.

Axon Ligands™ for Epigenetic research   Axon 5051 - Cell signaling and Oncology Library.xls                   


[1] A. Eccleston, R. Dhand. Signalling in cancer. Nature 441, 423, editorial note
[2] G.S. Martin. Cell signaling and cancer. Cancer Cell. 2003 Sep;4(3):167-74.

Items 121 to 150 of 1393 total

per page
  1. 3
  2. 4
  3. 5
  4. 6
  5. 7
Axon ID Name Description From price
2611 APS-2-79 Inhibitor of KSR and oncogenic Ras signaling €90.00
2191 AR 244555 Inverse agonist of Mas G-protein signaling €125.00
2394 AR-42 HDAC inhibitor €125.00
2136 AR03 Inhibitor of apurinic/apyrimidinic endonuclease 1 (APE1) €105.00
2679 AR7 RARα antagonist that stimulates chaperone-mediated autophagy €90.00
3433 ARB-272572 Potent, cellular active PD-L1 inhibitor €150.00
2307 ARM1 hydrobromide Novel type of LTA4H inhibitor that selectively blocks the conversion of LTA4 into LTB4 €92.00
3041 ARN 3236 Potent, selective, ATP-competitive, and orally available inhibitor of SIK2 €95.00
1979 ARN 509 Antagonist of androgen receptor (AR) €95.00
3220 ARN24139 Orally active topoisomerase II poison €130.00
1838 ARQ 197 c-MET tyrosine kinase Inhibitor €90.00
3084 ARS-1620 Potent, selective, and orally bioavailable covalent KRAS-G12C inhibitor €145.00
1992 AS 1517499 Potent and selective STAT6 inhibitor €130.00
2839 AS 1842856 Inhibitor of the Forkhead box protein O1 (FOXO1) €95.00
2187 AS 1892802 Potent, selective, ATP-competitive ROCK inhibitor €95.00
1424 AS 252424 PI3K inhibitor (p110-γ specific) €85.00
1436 AS 252424 bispotassium salt PI3K inhibitor (p110-γ specific) €95.00
2578 ASB14780 Potent, orally available inhibitor of cPLA2α; antiinflammatory drug €120.00
2757 Asciminib Potent and selective allosteric BCR-ABL1 inhibitor  Recently added €120.00
2179 ASK1 Inhibitor 10 Potent, selective, and orally bioavailable ASK1 inhibitor €130.00
1675 Asoprisnil Progesterone receptor (PR) modulator €130.00
2005 ASP 3026 Inhibitor of the oncogenic fusion kinase EML4-ALK €80.00
2787 ASP 9521 Inhibitor of 17 β–hydroxysteroid dehydrogenase type 5 €75.00
1986 AST 1306 tosylate ErbB2 and EGFR inhibitor €90.00
2166 AT 13148 dihydrochloride ATP-competitive inhibitor of multi-AGC kinases €70.00
1539 AT 7519 mesylate CDK inhibitor €80.00
2219 AT 9283 Multitargeted kinase inhibitor (Aurora A/B, JAK2/3, and BCR-Abl) €85.00
2043 Atorvastatin calcium Inhibitor of HMG-CoA reductase €60.00
2960 ATR-101 Potent, selective, and orally active ACAT1 inhibitor €145.00
1597 Aurora A inhibitor I Aurora A inhibitor €125.00

Items 121 to 150 of 1393 total

per page
  1. 3
  2. 4
  3. 5
  4. 6
  5. 7
Please wait...